HLA Sensitization Following Major Cortical Allograft Bone Procedures
Completed
Conditions studied: Bone Cancer
In brief
The purpose of this study is to find out whether or not antibodies to the donor bone are present in the blood of patients who receive the donor bone.
Key facts
- Study ID
- NCT00160719
- Run by
- University of Florida
- People needed
- 10
- Starts
- 1999-09-01
- Expected to finish
- 2010-03-01
- Last updated by the study team
- 2012-10-30
Who can join
Age: 12 and older, up to 80. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Patients twelve years or older who are scheduled for massive fresh-frozen human structural bone allograft implantation at participating centers will be given the opportunity to participate in the study. All patients must have a reconstruction of the involved long bone with either an intercalary graft, an osteoarticular graft, or an allograft/endoprosthesis composite graft. The junction or union site studied will be the cortical-cortical, host allograft junction site, not the cancellous interfaces.
You may not qualify if…
- Patients who do not require major weight bearing cortical allograft bone grafts will be excluded. Also, women who are or could potentially become pregnant will be excluded from the study.
Where it is running
- UF Orthopaedics and Sports Medicine Institute — Gainesville, Florida, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.